Sun Yan, Xiao Dong, Pan Xing-Hua, Zhang Ruo-Shuang, Cui Guang-Hui, Chen Xi-Gu
Center of Experimental Animals, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China.
World J Gastroenterol. 2007 May 21;13(19):2707-16. doi: 10.3748/wjg.v13.i19.2707.
To accurately and realistically elucidate human stem cell behaviors in vivo and the fundamental mechanisms controlling human stem cell fates in vivo, which is urgently required in regenerative medicine and treatments for some human diseases, a surrogate human-rat chimera model was developed.
Human-rat chimeras were achieved by in utero transplanting low-density mononuclear cells from human umbilical cord blood into the fetal rats at 9-11 d of gestation, and subsequently, a variety of methods, including flow cytometry, PCR as well as immunohistochemical assay, were used to test the human donor contribution in the recipients.
Of 29 live-born recipients, 19 had the presence of human CD45(+) cells in peripheral blood (PB) detected by flow cytometry, while PCR analysis on genomic DNA from 11 different adult tissues showed that 14 selected from flow cytometry-positive 19 animals possessed of donor-derived human cell engraftment in multiple tissues (i.e. liver, spleen, thymus, heart, kidney, blood, lung, muscle, gut and skin) examined at the time of tissue collection, as confirmed by detecting human beta2-microglobulin expression using immunohistochemistry. In this xenogeneic system, the engrafted donor-derived human cells persisted in multiple tissues for at least 6 mo after birth. Moreover, transplanted human donor cells underwent site-specific differentiation into CK18-positive human cells in chimeric liver and CD45-positive human cells in chimeric spleen and thymus of recipients.
Taken together, these findings suggest that we successfully developed human-rat chimeras, in which xenogeneic human cells exist up to 6 mo later. This humanized small animal model, which offers an in vivo environment more closely resembling to the situations in human, provides an invaluable and effective approach for in vivo investigating human stem cell behaviors, and further in vivo examining fundamental mechanisms controlling human stem cell fates in the future. The potential for new advances in our better understanding the living biological systems in human provided by investigators in humanized animals will remain promising.
为了准确、真实地阐明体内人类干细胞的行为以及控制体内人类干细胞命运的基本机制,这在再生医学和某些人类疾病的治疗中是迫切需要的,因此开发了一种人-大鼠嵌合体替代模型。
通过在妊娠9至11天时将人脐带血中的低密度单核细胞宫内移植到胎鼠体内来获得人-大鼠嵌合体,随后,使用多种方法,包括流式细胞术、聚合酶链反应(PCR)以及免疫组织化学分析,来检测受体中人类供体的贡献。
在29只存活出生的受体中,19只通过流式细胞术检测到外周血中存在人类CD45(+)细胞,而对来自11种不同成年组织的基因组DNA进行的PCR分析表明,从流式细胞术检测呈阳性的19只动物中选出的14只在组织收集时所检测的多个组织(即肝脏、脾脏、胸腺、心脏、肾脏、血液、肺、肌肉、肠道和皮肤)中存在供体来源的人类细胞植入,这通过免疫组织化学检测人类β2-微球蛋白的表达得到证实。在这个异种系统中,移植的供体来源的人类细胞在出生后至少6个月内在多个组织中持续存在。此外,移植的人类供体细胞在受体的嵌合肝脏中发生位点特异性分化为CK18阳性的人类细胞,在嵌合脾脏和胸腺中分化为CD45阳性的人类细胞。
综上所述,这些发现表明我们成功开发了人-大鼠嵌合体,其中异种人类细胞在6个月后仍然存在。这种人源化小动物模型提供了一个更类似于人类情况的体内环境,为体内研究人类干细胞行为以及未来进一步体内研究控制人类干细胞命运的基本机制提供了一种宝贵且有效的方法。研究人员通过人源化动物更好地理解人类活体生物系统方面取得新进展的潜力依然巨大。